Announcements Trials
Browse Landscape

Status

Recruiting 170Completed 112Active not recruiting 87Not yet recruiting 42Terminated 19Enrolling by invitation 9Suspended 4Withdrawn 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 28Neoplasms 27Prostatic Neoplasms 22Colorectal Neoplasms 16Head and Neck Neoplasms 13Pancreatic Neoplasms 12Brain Neoplasms 11Melanoma 10Neoplasm Metastasis 9Lung Neoplasms 9Squamous Cell Carcinoma of Head and Neck 8Carcinoma, Renal Cell 8Carcinoma, Non-Small-Cell Lung 8Triple Negative Breast Neoplasms 7Recurrence 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Follicular 7Leukemia, Myeloid, Acute 7Glioblastoma 7Multiple Myeloma 6Lymphoma 6Uterine Cervical Neoplasms 5Urinary Bladder Neoplasms 5Ovarian Neoplasms 5Leukemia 5Hematologic Neoplasms 5Sarcoma 4Lymphoma, B-Cell 4Liver Neoplasms 4Kidney Neoplasms 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Colonic Neoplasms × 1 year × Clear all
NCT05329870 2026-01-16

Does Genetic Susceptibility for Bleeding Affect Quantitative Faecal Immunochemical Test (qFIT) Results?

University of Edinburgh

Withdrawn
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT02151123 2025-09-26

Metabiomics Colon Cancer Clinical Research Study

Metabiomics Corp

Withdrawn
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡